160 related articles for article (PubMed ID: 15542835)
1. B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signaling.
Park S; Lee YJ; Lee HJ; Seki T; Hong KH; Park J; Beppu H; Lim IK; Yoon JW; Li E; Kim SJ; Oh SP
Mol Cell Biol; 2004 Dec; 24(23):10256-62. PubMed ID: 15542835
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of BTG2 activity, a transcriptional target of p53: evidences and hypothesis].
Puisieux A; Magaud JP
Bull Cancer; 1999 Apr; 86(4):358-64. PubMed ID: 10341341
[TBL] [Abstract][Full Text] [Related]
3. Spatio-temporal activation of Smad1 and Smad5 in vivo: monitoring transcriptional activity of Smad proteins.
Monteiro RM; de Sousa Lopes SM; Korchynskyi O; ten Dijke P; Mummery CL
J Cell Sci; 2004 Sep; 117(Pt 20):4653-63. PubMed ID: 15331632
[TBL] [Abstract][Full Text] [Related]
4. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
Lim IK
J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
[TBL] [Abstract][Full Text] [Related]
6. Ndrg2 regulates vertebral specification in differentiating somites.
Zhu H; Zhao J; Zhou W; Li H; Zhou R; Zhang L; Zhao H; Cao J; Zhu X; Hu H; Ma G; He L; Yao Z; Yao L; Guo X
Dev Biol; 2012 Sep; 369(2):308-18. PubMed ID: 22819676
[TBL] [Abstract][Full Text] [Related]
7. BTG2, its family and its tutor.
Duriez C; Moyret-Lalle C; Falette N; El-Ghissassi F; Puisieux A
Bull Cancer; 2004; 91(7-8):E242-53. PubMed ID: 15381462
[TBL] [Abstract][Full Text] [Related]
8. BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms.
Morel AP; Sentis S; Bianchin C; Le Romancer M; Jonard L; Rostan MC; Rimokh R; Corbo L
J Cell Sci; 2003 Jul; 116(Pt 14):2929-36. PubMed ID: 12771185
[TBL] [Abstract][Full Text] [Related]
9. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.
Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH
Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific expression of B-cell translocation gene 2 (BTG2) and its function in T-cell immune responses in a transgenic mouse model.
Terra R; Luo H; Qiao X; Wu J
Int Immunol; 2008 Mar; 20(3):317-26. PubMed ID: 18195048
[TBL] [Abstract][Full Text] [Related]
11. Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton.
Tijchon E; van Ingen Schenau D; van Opzeeland F; Tirone F; Hoogerbrugge PM; Van Leeuwen FN; Scheijen B
PLoS One; 2015; 10(7):e0131481. PubMed ID: 26218146
[TBL] [Abstract][Full Text] [Related]
12. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic human papillomaviruses block expression of the B-cell translocation gene-2 tumor suppressor gene.
Cullmann C; Hoppe-Seyler K; Dymalla S; Lohrey C; Scheffner M; Dürst M; Hoppe-Seyler F
Int J Cancer; 2009 Nov; 125(9):2014-20. PubMed ID: 19551855
[TBL] [Abstract][Full Text] [Related]
14. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
Midorikawa Y; Ishikawa S; Iwanari H; Imamura T; Sakamoto H; Miyazono K; Kodama T; Makuuchi M; Aburatani H
Int J Cancer; 2003 Feb; 103(4):455-65. PubMed ID: 12478660
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis.
Ficazzola MA; Fraiman M; Gitlin J; Woo K; Melamed J; Rubin MA; Walden PD
Carcinogenesis; 2001 Aug; 22(8):1271-9. PubMed ID: 11470758
[TBL] [Abstract][Full Text] [Related]
16. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
17. Sizn1 is a novel protein that functions as a transcriptional coactivator of bone morphogenic protein signaling.
Cho G; Lim Y; Zand D; Golden JA
Mol Cell Biol; 2008 Mar; 28(5):1565-72. PubMed ID: 18160706
[TBL] [Abstract][Full Text] [Related]
18. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein regulation of forkhead/winged helix transcription factor Foxc2 (Mfh1) in a murine mesodermal cell line C1 and in skeletal precursor cells.
Nifuji A; Miura N; Kato N; Kellermann O; Noda M
J Bone Miner Res; 2001 Oct; 16(10):1765-71. PubMed ID: 11585339
[TBL] [Abstract][Full Text] [Related]
20. The RING domain of PIASy is involved in the suppression of bone morphogenetic protein-signaling pathway.
Imoto S; Sugiyama K; Yamamoto T; Matsuda T
Biochem Biophys Res Commun; 2004 Jun; 319(1):275-82. PubMed ID: 15158472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
